JTE-013
|
|
- CAS-Nr.
- 383150-41-2
- Englisch Name:
- JTE-013
- Synonyma:
- CS-2553;JTE-013 HCl;JTE-013;JTE 013;JTE013;LPL Receptor,Apoptosis,JTE-013,Inhibitor,Lysophospholipid Receptor,JTE 013,inhibit,JTE013;1-(2,6-dichloro-4-pyridyl)-3-[(4-isopropyl-1,3-dimethyl-pyrazolo[3,4-b]pyridin-6-yl)amino]urea;1-(2,6-dichloropyridin-4-yl)-3-[(1,3-dimethyl-4-propan-2-ylpyrazolo[3,4-b]pyridin-6-yl)amino]urea;1-[1,3-Dimethyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-4-(3,5-dichloro-4-pyridinyl)-semicarbazide;1-[1,3-Dimethyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-4-(2,6-dichloro-4-pyridinyl)-semicarbazide;N-(2,6-Dichloropyridin-4-yl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazine-1-carboxamide;N-(2,6-Dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazinecarboxamide
- CBNumber:
- CB52591408
- Summenformel:
- C17H19Cl2N7O
- Molgewicht:
- 408.29
- MOL-Datei:
- 383150-41-2.mol
|
JTE-013 Eigenschaften
- Dichte
- 1.50±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- L?slichkeit
- DMSO: ≥20mg/mL
- pka
- 9.32±0.43(Predicted)
- Aggregatzustand
- powder
- Farbe
- white to off-white
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Kennzeichnung gef?hrlicher |
T |
|
|
R-S?tze: |
25 |
|
|
S-S?tze: |
45 |
|
|
RIDADR |
UN 2811 6.1 / PGIII |
|
|
WGK Germany |
3 |
|
|
Bildanzeige (GHS) |
|
Alarmwort |
Achtung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H301 |
Giftig bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 3 |
Achtung |
src="/GHS06.jpg" width="20" height="20" /> |
P264, P270, P301+P310, P321, P330,P405, P501 |
|
Sicherheit |
P301+P310 |
BEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen. |
|
JTE-013 Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Sphingosine-
1-
phosphate (S1P) is a bioactive lipid that exhibits a broad spectrum of biological activities including cell proliferation, survival, migration, cytoskeletal organization, and morphogenesis. It exerts its activity by binding to five distinct G protein-
coupled receptors, S1P
1/EDG-
1, S1P
2/EDG-
5, S1P
3/EDG-
3, S1P
4/EDG-
6, and S1P
5/EDG-
8. JTE-
013 is a potent, selective sphingosine-
1-
phosphate 2 (S1P
2) receptor antagonist that binds to the human and rat receptors with IC
50 values of 17 and 22 nM, respectively, (IC
50 values >10 μM for human S1P
1 and S1P
3). It reverses the inhibitory effects of S1P on cell migration of vascular endothelial cells and smooth muscle cells. Similarly, JTE-
013 reverses the inhibition of S1P on invasion and migration of B16 melanoma cells. JTE-
013 inhibits S1P-
induced contraction of, as well as cyclic AMP accumulation in, coronary artery smooth muscle cells.
Verwenden
JTE-013 has been used in
in vitro blood?brain barrier (BBB) and blood?tumor barrier (BTB) assays.
Biochem/physiol Actions
JTE-013 can enhance the excitability of small-diameter sensory neurons. It has the ability to repress sphingosine 1-phosphate (S1P)-mediated cellular migration.
JTE-013 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
JTE-013 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 69)Lieferanten
- 1-[1,3-Dimethyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-4-(2,6-dichloro-4-pyridinyl)-semicarbazide
- 1-(2,6-dichloro-4-pyridyl)-3-[(4-isopropyl-1,3-dimethyl-pyrazolo[3,4-b]pyridin-6-yl)amino]urea
- 1-[1,3-Dimethyl-4-(2-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-4-(3,5-dichloro-4-pyridinyl)-semicarbazide
- CS-2553
- N-(2,6-Dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]hydrazinecarboxamide
- JTE-013;JTE 013;JTE013
- 1-(2,6-dichloropyridin-4-yl)-3-[(1,3-dimethyl-4-propan-2-ylpyrazolo[3,4-b]pyridin-6-yl)amino]urea
- Hydrazinecarboxamide, N-(2,6-dichloro-4-pyridinyl)-2-[1,3-dimethyl-4-(1-methylethyl)-1H-pyrazolo[3,4-b]pyridin-6-yl]-
- N-(2,6-Dichloropyridin-4-yl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazine-1-carboxamide
- JTE-013 HCl
- LPL Receptor,Apoptosis,JTE-013,Inhibitor,Lysophospholipid Receptor,JTE 013,inhibit,JTE013
- 383150-41-2
- C17H19Cl2N7O